Preimplantation Genetic Diagnosis (PGD)

Getting you a free of hereditary diseases baby

High complexity procedures

Genetic Diagnosis in Cancun, Mexico

This procedure consists on taking one cell of the embryo to later perform a genetic diagnosis through FICH or PCR procedure. With this procedure you can dismiss 95% of all chromosomal illness which can affect the human being. This techniques of molecular biology are of far more complexity and are designated for aged women with good follicular dotes and/or in couples which may be carrying some preventable genetic mutation. The PGC is elaborated before the embryo transfer and can help us to avoid the transmission of inherited diseases to our children.

When is this procedure performed?

This technique performed in Fertility Center Cancun’s Laboratories, lets us study embryo’s DNA in order to be able to select those which have determined inherited genetic or chromosomal disorders and which are embarked in the process of any in Vitro Fecundation procedure.

PGD with embryos

After performing the in Vitro Fecundation and before the uterus’s transfer, mostly when the embryos are in their third development day, the genetic material is studied in order to detect any concrete alterations.

To perform the analysis of the genetic material we have to carry out a biopsy in each of the embryos to separate the healthy ones from the ones with a concrete genetic disorder in order to transfer only healthy embryos to the uterus and assure the baby’s health.

PGD with eggs

Same as the PGD with embryos, this technique helps us detect maternal genetic or chromosomal inherited diseases through a biopsy of the ovule before the embryo is formed.

To perform this analysis, a small incision is performed in the pellucid zoned which covers the ovule in order to be able to extract the polar corpuscle and study it; after which we proceed with the intracytoplasmic sperm injection (ICSI) with the previously selected spermatozoids. After two days, when we get the results, we are able to select only the embryos which derive from healthy oocytes.


  • Couples with recurrent abortions history.
  • Couples with risk of inheritance diseases.
  • For over 35 years old women.
  • Implantation failure after a series of IVF cycles.
  • Men with alterations in sperm meiosis.